Literature DB >> 16634890

Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals.

H J Bovenschen1, M Tjioe, H Vermaat, D de Hoop, B M J Witteman, R W A Janssens, T J Stoof, P C M van de Kerkhof.   

Abstract

BACKGROUND: Eruptive naevi have been described to potentially arise in immune compromised patients.
OBJECTIVES: We describe three patients with eruptive benign melanocytic naevi during a phase of immunosuppressive therapy. METHODS/DIAGNOSIS: Two patients with Crohn disease were treated with either azathioprine monotherapy or a combination of azathioprine and infliximab, when eruptive naevi arose particularly at the palms and soles. Our third patient with plaque psoriasis developed eruptive naevi during two episodes of treatment: during a course with the biological agent alefacept and during etanercept therapy.
CONCLUSIONS: We conclude that treatment with the recently available biological agents might be associated with the formation of eruptive naevi. Although positive evidence for the occurrence of malignant pigmented lesions is lacking, alertness to the development of eruptive melanocytic naevi during treatment with biological agents is indicated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634890     DOI: 10.1111/j.1365-2133.2006.07189.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  12 in total

1.  Surgical suturing-induced melanocytic nevi. A new type of eruptive melanocytic nevi?

Authors:  Alexander C Katoulis; Dimitrios Sgouros; Giuseppe Argenziano; Efstathios Rallis; Ioannis Panayiotides; Dimitrios Rigopoulos
Journal:  J Dermatol Case Rep       Date:  2016-11-30

2.  Sorafenib-induced eruptive melanocytic lesions.

Authors:  Heidi H Kong; Vincent Sibaud; Maria L Chanco Turner; Tito Fojo; Thomas J Hornyak; Christine Chevreau
Journal:  Arch Dermatol       Date:  2008-06

3.  Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin: Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malignant Melanoma After Initiating Treatment with Vemurafenib.

Authors:  Philip R Cohen; Agop Y Bedikian; Kevin B Kim
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

4.  [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis].

Authors:  S A Braun; D Helbig; J Frank; S Hanneken
Journal:  Hautarzt       Date:  2012-10       Impact factor: 0.751

5.  Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer.

Authors:  Alberto Meneguzzo; Annalisa Lazzarotto; Mauro Alaibac
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

6.  A case with postchemotherapy eruptive compound nevus.

Authors:  Selma Bakar Dertlioglu; Muharrem Bitiren; Demet Cicek
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

7.  Nevogenesis: a benign metastatic process?

Authors:  Andrew L Ross; Margaret I Sanchez; James M Grichnik
Journal:  ISRN Dermatol       Date:  2011-04-05

8.  Dysplastic Nevus with Eruptive Melanocytic Lesions That Developed during Nilotinib Therapy for Chronic Myeloid Leukemia.

Authors:  Joo Hyun Lee; Jin Hee Kang; Baik Kee Cho; Hyun Jeong Park
Journal:  Ann Dermatol       Date:  2015-12-07       Impact factor: 1.444

9.  Eruptive melanocytic nevi heralding the diagnosis of metastatic malignant melanoma: A case report.

Authors:  Nour Kibbi; Stephan Ariyan; Frederick Slogoff; Rossitza Lazova; Jennifer Nam Choi
Journal:  JAAD Case Rep       Date:  2015-03-06

10.  Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.

Authors:  Laura Timares; Craig A Elmets; Tahseen H Nasti; Nabiha Yusuf; Mohammad Asif Sherwani; Mohammad Athar
Journal:  Cancer Prev Res (Phila)       Date:  2020-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.